Our privacy policy describes how Fidessa uses cookies on our website. If you continue using our website, you are consenting to our use of cookies. OK

Deriving Equities Market Share

Last Friday, the 17th September, highlighted again the interrelationship between derivatives and equities in terms of fragmentation. The third Friday of the month is associated with futures and options expiration and so market participants close out positions with a resultant surge in volumes on the primary exchange. You can see this effect clearly in the US, Canada and London as volumes crystallised around the NYSE, TSX and LSE respectively.

The question this raises is what quality of execution these market participants received (and whether they care). Take London, for example. The LSE‘s average volume of the FTSE 100 is around 30%, yet last Friday this jumped to nearly 45%. The same was true of New York where volume on the NYSE jumped by about a third in terms of trading in S&P 500 stocks last Friday.

I guess if you are the owner of an ‘in the money’ option ticket then maybe you simply want to cash in your winnings, especially if you know there are probably plenty of other people in the queue behind you.

That’s why most of this volume gets sucked into the pre-market auctions operated by the primary market centres. Nevertheless, in these days of super smart order routing, it seems odd that these folks don’t have the same sensitivity to achieving the absolute best price for the underlying cash leg.

As it stands currently, though, it does seem to be an area that the primary market centres have a bit of a stranglehold over, especially as this effect seems to be a global phenomenon. During the summer there was quite a bit of speculation in Europe over how derivatives might be used as the next ammunition in the battle between venues. There are some obvious challenges in terms of fungibility and clearing, but any venue that can find a way to leverage the correlation we see every third Friday looks to be on to winner.

Leave a comment

Copyright © 2019 Fidessa Group Holdings Limited. All rights reserved.

The information contained within this website is provided for informational purposes only. Fidessa will use reasonable care to ensure that information is accurate at the time it is made available, and for the duration that it remains on the site. The information may be changed by Fidessa at any time without notice. We also reserve the right to close the website at any time. No representation or warranty, expressed or implied, is given on behalf of Fidessa or any of its respective directors, employees, agents, or advisers as to the accuracy or completeness of the information or opinions contained herein or its suitability for any purpose and, save in the case of fraud, all liability for direct, indirect, special, consequential or other loss or damages of whatever kind that may arise from use of the website is hereby excluded to the fullest extent permitted by law. Any decisions you make based on the information in this website are your sole responsibility and information on the website should not be relied upon in connection with any investment decision.

The copyright of this website belongs to Fidessa. All other intellectual property rights are reserved.

Fragulator® is a registered trademark of Fidessa Group Holdings Limited.

Reproduction or redistribution of this information is prohibited except with written permission from Fidessa.